TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13A
PLOS Biology · 2023
DOI: 10.1371/journal.pbio.3002028 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2023. Verfasst von Yuka Koike und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Heterogeneous-Nuclear Ribonucleoprotein L. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NINDS NIH HHS, NIA NIH HHS, NIH.
Abstract (Originalsprache)
A major function of TAR DNA-binding protein-43 (TDP-43) is to repress the inclusion of cryptic exons during RNA splicing. One of these cryptic exons is in UNC13A , a genetic risk factor for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The accumulation of cryptic UNC13A in disease is heightened by the presence of a risk haplotype located within the cryptic exon itself. Here, we revealed that TDP-43 extreme N-terminus is important to repress UNC13A cryptic exon inclusion. Further, we found hnRNP L, hnRNP A1, and hnRNP A2B1 bind UNC13A RNA and repress cryptic exon inclusion, independently of TDP-43. Finally, higher levels of hnRNP L protein associate with lower burden of UNC13A cryptic RNA in ALS/FTD brains. Our findings suggest that while TDP-43 is the main repressor of UNC13A cryptic exon inclusion, other hnRNPs contribute to its regulation and may potentially function as disease modifiers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.
- Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, Florida, United States of America.
- Center for Alzheimer's and Related Dementias, National Institute on Aging, NIH, Bethesda, Maryland, United States of America.
- National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland, United States of America.
ORCID-Profile: Leonard Petrucelli, Mercedes Prudencio
Förderung
- NINDS NIH HHS
- NIA NIH HHS
- NIH
- Target ALS
- Robert Packard Center for ALS Research, Johns Hopkins University
- Milton Safenowitz Postdoctoral Fellowship Program from the Amyotrophic Lateral Sclerosis Association
- BrightFocus Foundation
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Koike, Y., Pickles, S., Estades Ayuso, V., Jansen-West, K., Qi, Y. A., Li, Z., Daughrity, L. M., Yue, M., Zhang, Y. J., Cook, C. N., Dickson, D. W., Ward, M., Petrucelli, L., & Prudencio, M. (2023). TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13A. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002028
Vancouver
Koike Y, Pickles S, Estades Ayuso V, Jansen-West K, Qi YA, Li Z, et al. TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13A. PLOS Biology. 2023. doi:10.1371/journal.pbio.3002028
BibTeX
@article{Koike2023,
author = {Koike, Yuka and Pickles, Sarah and Estades Ayuso, Virginia and Jansen-West, Karen and Qi, Yue A and Li, Ziyi and Daughrity, Lillian M and Yue, Mei and Zhang, Yong-Jie and Cook, Casey N and Dickson, Dennis W and Ward, Michael and Petrucelli, Leonard and Prudencio, Mercedes},
title = {TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13A},
journal = {PLOS Biology},
year = {2023},
doi = {10.1371/journal.pbio.3002028}
}
EUVIMED